Literature DB >> 2014978

Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery.

G Privitera1, P Scarpellini, G Ortisi, G Nicastro, R Nicolin, F de Lalla.   

Abstract

A total of 108 volunteers undergoing an elective surgical procedure were randomly given a single 2-g intravenous prophylactic dose of either a cephalosporin or mezlocillin. Stool samples were cultured for Clostridium difficile the day before the operation and later on postoperative days 4, 7, and 14. C. difficile was detected in 23.0% of patients who received a cephalosporin (cefoxitin, 8.3%; cefazolin, 14.3%; cefotetan, 20.0%; ceftriaxone, 25.0%; cefoperazone, 43.7%), in 3.3% of patients given mezlocillin, and in none of 15 control volunteers given no antimicrobial agent. No patient experienced diarrhea.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014978      PMCID: PMC244972          DOI: 10.1128/AAC.35.1.208

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Toxigenicity of Clostridium difficile isolates from patients and healthy adults.

Authors:  S Nakamura; S Nakashio; T Inamatsu; N Nishida; N Taniguchi; S Nishida
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

2.  Isolation of Clostridium difficile from patients and the environment of hospital wards.

Authors:  H Malamou-Ladas; S O'Farrell; J Q Nash; S Tabaqchali
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

3.  Clinical and laboratory observations in Clostridium difficile colitis.

Authors:  J G Bartlett; N S Taylor; T Chang; J Dzink
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

4.  Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital.

Authors:  F de Lalla; G Privitera; G Ortisi; G Rizzardini; D Santoro; A Pagano; E Rinaldi; P Scarpellini
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

5.  Nosocomial spread of Clostridium difficile.

Authors:  A M Savage; R H Alford
Journal:  Infect Control       Date:  1983 Jan-Feb

6.  Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis.

Authors:  M E Mulligan; W L George; R D Rolfe; S M Finegold
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

7.  Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

Authors:  W L George; R D Rolfe; S M Finegold
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

8.  Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment.

Authors:  R Fekety; K H Kim; D Brown; D H Batts; M Cudmore; J Silva
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

9.  Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.

Authors:  K H Kim; R Fekety; D H Batts; D Brown; M Cudmore; J Silva; D Waters
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

10.  Treatment of Clostridium difficile-associated disease with teicoplanin.

Authors:  F de Lalla; G Privitera; E Rinaldi; G Ortisi; D Santoro; G Rizzardini
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

View more
  21 in total

Review 1.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Effects of an Educational Module in Rationalizing Surgical Prophylaxis.

Authors:  Neena Nagdeo; R Sonarkar; V R Thombare; M Akhtar; S Dasgupta
Journal:  Indian J Surg       Date:  2015-06-10       Impact factor: 0.656

3.  Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.

Authors:  Tara N Palmore; SeJean Sohn; Sharp F Malak; Janet Eagan; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2005-08       Impact factor: 3.254

Review 4.  Treatment of refractory and recurrent Clostridium difficile infection.

Authors:  Christina M Surawicz; Jacob Alexander
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04-19       Impact factor: 46.802

Review 5.  Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia.

Authors:  H Andrew Wilsey; Donna R Burgess; David S Burgess
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

6.  The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients.

Authors:  K C Kent; M S Rubin; L Wroblewski; P A Hanff; W Silen
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

7.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

8.  Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Authors:  Brian T Bateman; Jeremy A Rassen; Sebastian Schneeweiss; Katsiaryna Bykov; Jessica Myers Franklin; Joshua J Gagne; Jennifer M Polinski; Jun Liu; Alexander Kulik; Michael A Fischer; Niteesh K Choudhry
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-28       Impact factor: 5.209

Review 9.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

10.  Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem.

Authors:  Fausto de Lalla
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.